We’re here to help you achieve your strategic objectives.
Q2 2026 Healthcare M&A Spotlight
July 23, 2026 | Insights
In Q2 2026, healthcare M&A extended its momentum, with deal volume narrowly surpassing Q1 to mark a second consecutive quarter of sequential growth. The sector remains more insulated from geopolitical headwinds and the broader market slowdown than most, helping it capture a growing share of overall M&A volume. Against that backdrop, sponsors are increasingly willing to underwrite assets at premium multiples in favored subsectors. Activity cooled in June but has begun to rebound following the July 4th holiday. Given this setup, we expect Q3 closings to come in slightly lower, as several second-half processes launch with an eye toward a Q4 2026 or Q1 2027 close.
Download the report by filling out the form. Please contact us to request more information.
Download Now
CONTACT INFORMATION
Rebecca Springer
Senior Director, Market Development
Caitlin Zager
Director, Market Development
Collin Anderson
Associate, Market Development
ABOUT BAILEY & COMPANY
Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com
